HIGHLIGHTS
- who: Lingyu Zhu and colleagues from the Engineering Research Center for Cereal Fermentation and Food Biomanufacturing, Jiangnan University, Wuxi, China have published the paper: Recombinant Human Arresten and Canstatin Inhibit Angiogenic Behaviors of HUVECs via Inhibiting the PI3K/Akt Signaling Pathway, in the Journal: (JOURNAL)
- what: In this study human arresten and canstatin were recombinantly expressed in_(E. and their effects on the proliferation migration and tube formation of human umbilical vein endothelial cells (HUVECs) were evaluated. This study provides a novel strategy for the acquisition of recombinant human arresten and canstatin, and contributes to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.